Athira Pharma Statistics
Share Statistics
Athira Pharma has 39.04M
shares outstanding. The number of shares has increased by 1.86%
in one year.
| Shares Outstanding | 39.04M |
| Shares Change (YoY) | 1.86% |
| Shares Change (QoQ) | 0.97% |
| Owned by Institutions (%) | 46.58% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,898 |
| FTD / Avg. Volume | 1.37% |
Short Selling Information
The latest short interest is 855.1K, so 2.19% of the outstanding
shares have been sold short.
| Short Interest | 855.1K |
| Short % of Shares Out | 2.19% |
| Short % of Float | 2.61% |
| Short Ratio (days to cover) | 4.27 |
Valuation Ratios
The PE ratio is -0.23 and the forward
PE ratio is -0.72.
Athira Pharma's PEG ratio is
0.01.
| PE Ratio | -0.23 |
| Forward PE | -0.72 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.5 |
| P/FCF Ratio | -0.23 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Athira Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18,
with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.18 |
| Quick Ratio | 4.18 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-3,728,461.54 |
| Employee Count | 26 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -88.24% in the
last 52 weeks. The beta is 3.05, so Athira Pharma's
price volatility has been higher than the market average.
| Beta | 3.05 |
| 52-Week Price Change | -88.24% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.81 |
| Relative Strength Index (RSI) | 45.42 |
| Average Volume (20 Days) | 212,275 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -96.78M |
| Net Income | -96.94M |
| EBITDA | -95.97M |
| EBIT | -96.94M |
| Earnings Per Share (EPS) | -2.52 |
Full Income StatementBalance Sheet
The company has 48.44M in cash and 1.22M in
debt, giving a net cash position of 47.22M.
| Cash & Cash Equivalents | 48.44M |
| Total Debt | 1.22M |
| Net Cash | 47.22M |
| Retained Earnings | -406.15M |
| Total Assets | 43.51M |
| Working Capital | 34.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -97.17M
and capital expenditures -33K, giving a free cash flow of -97.2M.
| Operating Cash Flow | -97.17M |
| Capital Expenditures | -33K |
| Free Cash Flow | -97.2M |
| FCF Per Share | -2.53 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
